1272 related articles for article (PubMed ID: 12004803)
1. Isolation perfusion of the liver.
Carroll NM; Alexander HR
Cancer J; 2002; 8(2):181-93. PubMed ID: 12004803
[TBL] [Abstract][Full Text] [Related]
2. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer.
Bartlett DL; Libutti SK; Figg WD; Fraker DL; Alexander HR
Surgery; 2001 Feb; 129(2):176-87. PubMed ID: 11174711
[TBL] [Abstract][Full Text] [Related]
3. Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.
Rothbarth J; Tollenaar RA; Schellens JH; Nortier JW; Kool LJ; Kuppen PJ; Mulder GJ; van de Velde CJ
Eur J Cancer; 2004 Aug; 40(12):1812-24. PubMed ID: 15288282
[TBL] [Abstract][Full Text] [Related]
4. Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.
Alexander HR; Libutti SK; Bartlett DL; Pingpank JF; Kranda K; Helsabeck C; Beresnev T
Cancer; 2002 Aug; 95(4):730-6. PubMed ID: 12209715
[TBL] [Abstract][Full Text] [Related]
5. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
Alexander HR; Libutti SK; Bartlett DL; Puhlmann M; Fraker DL; Bachenheimer LC
Clin Cancer Res; 2000 Aug; 6(8):3062-70. PubMed ID: 10955785
[TBL] [Abstract][Full Text] [Related]
6. Transarterial perfusion of liver metastases.
Weinreich DM; Alexander HR
Semin Oncol; 2002 Apr; 29(2):136-44. PubMed ID: 11951211
[TBL] [Abstract][Full Text] [Related]
7. Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver.
Alexander HR; Bartlett DL; Libutti SK
Oncologist; 2000; 5(5):416-24. PubMed ID: 11040278
[TBL] [Abstract][Full Text] [Related]
8. Development of isolated hepatic perfusion for patients who have unresectable hepatic malignancies.
Jones A; Alexander HR
Surg Oncol Clin N Am; 2008 Oct; 17(4):857-76, x. PubMed ID: 18722923
[TBL] [Abstract][Full Text] [Related]
9. The past decade of experience with isolated hepatic perfusion.
Grover A; Alexander HR
Oncologist; 2004; 9(6):653-64. PubMed ID: 15561809
[TBL] [Abstract][Full Text] [Related]
10. Outcome analysis of a decade-long experience of isolated hepatic perfusion for unresectable liver metastases at a single institution.
Magge D; Choudry HA; Zeh HJ; Cunningham DE; Steel J; Holtzman MP; Jones HL; Pingpank JF; Bartlett DL; Zureikat AH
Ann Surg; 2014 May; 259(5):953-9. PubMed ID: 24169176
[TBL] [Abstract][Full Text] [Related]
11. Isolated hepatic perfusion chemotherapy for unresectable malignant hepatic tumors.
Ku Y; Tominaga M; Iwasaki T; Fukumoto T; Kuroda Y
Int J Clin Oncol; 2002 Apr; 7(2):82-90. PubMed ID: 12018114
[TBL] [Abstract][Full Text] [Related]
12. Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan.
Lindnér P; Fjälling M; Hafström L; Kierulff-Nielsen H; Mattsson J; Scherstén T; Rizell M; Naredi P
Eur J Surg Oncol; 1999 Apr; 25(2):179-85. PubMed ID: 10218462
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer.
Zeh HJ; Brown CK; Holtzman MP; Egorin MJ; Holleran JL; Potter DM; Bartlett DL
Ann Surg Oncol; 2009 Feb; 16(2):385-94. PubMed ID: 19034580
[TBL] [Abstract][Full Text] [Related]
14. Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy.
Alexander HR; Libutti SK; Pingpank JF; Bartlett DL; Helsabeck C; Beresneva T
Ann Surg Oncol; 2005 Feb; 12(2):138-44. PubMed ID: 15827794
[TBL] [Abstract][Full Text] [Related]
15. Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center.
Alexander HR; Bartlett DL; Libutti SK; Pingpank JF; Fraker DL; Royal R; Steinberg SM; Helsabeck CB; Beresneva TH
Ann Surg Oncol; 2009 Jul; 16(7):1852-9. PubMed ID: 19434456
[TBL] [Abstract][Full Text] [Related]
16. [Isolated hepatic perfusion for treatment of unresectable malignant tumor].
Wang Xd; Yang Rj
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):225-8. PubMed ID: 18458704
[TBL] [Abstract][Full Text] [Related]
17. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver.
Alexander HR; Bartlett DL; Libutti SK; Fraker DL; Moser T; Rosenberg SA
J Clin Oncol; 1998 Apr; 16(4):1479-89. PubMed ID: 9552055
[TBL] [Abstract][Full Text] [Related]
18. Isolated hepatic perfusion with high-dose melphalan results in immediate alterations in tumor gene expression in patients with metastatic ocular melanoma.
Varghese S; Xu H; Bartlett D; Hughes M; Pingpank JF; Beresnev T; Alexander HR
Ann Surg Oncol; 2010 Jul; 17(7):1870-7. PubMed ID: 20221901
[TBL] [Abstract][Full Text] [Related]
19. Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies.
Libutti SK; Barlett DL; Fraker DL; Alexander HR
J Am Coll Surg; 2000 Nov; 191(5):519-30. PubMed ID: 11085732
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion.
Feldman ED; Wu PC; Beresneva T; Helsabeck C; Rodriguez M; Bartlett DL; Libutti SK; Pingpank JF; Alexander HR
J Gastrointest Surg; 2004 Feb; 8(2):200-7. PubMed ID: 15036196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
